Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematologic Cancer or Myelodysplastic Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

May 31, 2011

Conditions
LeukemiaMyelodysplastic Syndromes
Interventions
PROCEDURE

nonmyeloablative allogeneic hematopoietic stem cell transplantation

administration of conditioning therapy including immunosuppressive agents plus alkylating agents and infusing hematopoietic progenitor cells collected from the donor

PROCEDURE

peripheral blood stem cell transplantation

infusion of donor hematopoietic cells collected by leukapheresis after mobilization with growth factor

Trial Locations (1)

138-736

Asan Medical Center - University of Ulsan College of Medicine, Seoul

Sponsors
All Listed Sponsors
collaborator

Pusan National University Hospital

OTHER

lead

Asan Medical Center

OTHER